Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis

Medical Oncology

Volumn 30, Issue 2, 2013, Pages

  Jiang, Tao ^a   Tang, Hua Mei ^a   Wu, Ze Hua ^a   Chen, Jian ^a   Lu, Su ^a   Zhou, Chong Zhi ^a   Yan, Dong Wang ^a   Peng, Zhi Hai ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Colon cancer; Cullin 4B; Immunohistochemistry; Prognosis

Indexed keywords

CULLIN 4B; MESSENGER RNA; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; CUL4B PROTEIN, HUMAN; CULLIN; TUMOR MARKER;

AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE RISK; TISSUE MICROARRAY; TUMOR INVASION; CHI SQUARE DISTRIBUTION; COLON TUMOR; DISEASE COURSE; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; CHI-SQUARE DISTRIBUTION; COLONIC NEOPLASMS; CULLIN PROTEINS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84876950004     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-013-0534-7     Document Type: Article

References (29)

1. Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, et al. Colon cancer. Critical Rev Oncol Hematol. 2010;74(2):106-33.
2. Nelson RS, Thorson AG. Colorectal cancer screening. Curr Oncol Rep. 2009;11(6):482-9.
3. Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol. 2011;6:479-507.
4. Zhang S, Cui Y, Weng Z, Gong X, Chen M, Zhong B. Changes on the disease pattern of primary colorectal cancers in Southern China: a retrospective study of 20 years. Int J Colorectal Dis. 2009;24(8):943-9.
5. Yan DW, Li DW, Yang YX, Xia J, Wang XL, Zhou CZ, et al. Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery. Br J Cancer. 2010;103(7):961-9.
6. Yan DW, Fan JW, Yu ZH, Li MX, Wen YG, Li DW, et al. Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. Biochim Biophys Acta. 2012;1822(6):918-26.
7. Yamaguchi H, Hsu JL, Hung MC. Regulation of ubiquitination-mediated protein degradation by survival kinases in cancer. Frontiers Oncol. 2012;2:15.
8. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010;463(7283):899-905.
9. Yasui K, Arii S, Zhao C, Imoto I, Ueda M, Nagai H, et al. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology. 2002;35(6):1476-84.
10. Chen LC, Manjeshwar S, Lu Y, Moore D, Ljung BM, Kuo WL, et al. The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. Cancer Res. 1998;58(16):3677-83.
11. Schindl M, Gnant M, Schoppmann SF, Horvat R, Birner P. Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. Anticancer Res. 2007;27(2):949-52.
12. Lee J, Zhou P. Pathogenic role of the CRL4 ubiquitin ligase in human disease. Frontiers Oncol. 2012;2:21.
13. Marin I. Diversification of the cullin family. BMC Evol Biol. 2009;9:267.
14. Kerzendorfer C, Whibley A, Carpenter G, Outwin E, Chiang SC, Turner G, et al. Mutations in Cullin 4B result in a human syndrome associated with increased camptothecin-induced topoisomerase I-dependent DNA breaks. Hum Mol Genet. 2010;19(7):1324-34.
15. Kerzendorfer C, Hart L, Colnaghi R, Carpenter G, Alcantara D, Outwin E, et al. CUL4B-deficiency in humans: understanding the clinical consequences of impaired Cullin 4-RING E3 ubiquitin ligase function. Mech Ageing Dev. 2011;132(8-9):366-73.
16. Zou Y, Mi J, Cui J, Lu D, Zhang X, Guo C, et al. Characterization of nuclear localization signal in the N terminus of CUL4B and its essential role in cyclin E degradation and cell cycle progression. J Biol Chem. 2009;284(48):33320-32.
17. Li D, Yan D, Tang H, Zhou C, Fan J, Li S, et al. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Ann Surg Oncol. 2009;16(12):3499-506.
18. Wang X, Yan D, Teng M, Fan J, Zhou C, Li D, et al. Reduced expression of PER3 is associated with incidence and development of colon cancer. Ann Surg Oncol. 2012;19(9):3081-8.
19. Wei W, Lin HK. The key role of ubiquitination and sumoylation in signaling and cancer: a research topic. Frontiers Oncol. 2012;2:187.
20. Jia S, Kobayashi R, Grewal SI. Ubiquitin ligase component Cul4 associates with Clr4 histone methyltransferase to assemble heterochromatin. Nat Cell Biol. 2005;7(10):1007-13.
21. Jackson S, Xiong Y. CRL4 s: the CUL4-RING E3 ubiquitin ligases. Trends Biochem Sci. 2009;34(11):562-70.
22. Higa LA, Yang X, Zheng J, Banks D, Wu M, Ghosh P, et al. Involvement of CUL4 ubiquitin E3 ligases in regulating CDK inhibitors Dacapo/p27Kip1 and cyclin E degradation. Cell Cycle. 2006;5(1):71-7.
23. Tarpey PS, Raymond FL, O'Meara S, Edkins S, Teague J, Butler A, et al. Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am J Hum Genet. 2007;80(2):345-52.
24. Zou Y, Liu Q, Chen B, Zhang X, Guo C, Zhou H, et al. Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am J Hum Genet. 2007;80(3):561-6.
25. Lawson JC, Blatch GL, Edkins AL. Cancer stem cells in breast cancer and metastasis. Breast Cancer Res Treat. 2009;118(2):241-54.
26. Hu J, Zacharek S, He YJ, Lee H, Shumway S, Duronio RJ, et al. WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1-CUL4-ROC1 ligase. Genes Dev. 2008;22(7):866-71.
27. Katiyar S, Liu E, Knutzen CA, Lang ES, Lombardo CR, Sankar S, et al. REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase. EMBO Rep. 2009;10(8):866-72.
28. Sung CK, Dahl J, Yim H, Rodig S, Benjamin TL. Transcriptional and post-translational regulation of the quiescence factor and putative tumor suppressor p150(Sal2). FASEB J Off Publ Fed Am Soc Exp Biol. 2011;25(4):1275-83.
29. Hu H, Yang Y, Ji Q, Zhao W, Jiang B, Liu R, et al. CRL4B Catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to Promote Tumorigenesis. Cancer Cell. 2012;22(6):781-95.